
Caption 2. Increases in CBF (red) and decreases in CBF (blue) during the premonitory phase relative to baseline in the post-hoc paired t-test (n=25).
CGRP Forum is made possible thanks to support from AbbVie, Lilly, Organon and Pfizer, all of whom have no influence or control over editorial content. More information is available here »